Agents, such as celecoxib, a cyclooxygenase-2 inhibitor, and resveratrol, a botanical from the skin of red grapes, have been evaluated for their antitumor properties using in vitro and in vivo models of malignant mesothelioma [21,22,23]. The gene discussed is PTGS2; the disease is malignant mesothelioma.